Risks and limits of APOE Training

The concept of APOE-based training (e.g., tailored exercise for APOE4 carriers to reduce Alzheimer's risk) is intriguing but lacks robust scientific validation. APOE4 is a well-established risk factor for Alzheimer's disease, but its effect size is modest. While physical activity is broadly neuroprotective, no specific training regimen has been proven to differentially benefit APOE4 carriers. Risks include overinterpretation of the genetic result, neglecting other critical lifestyle factors (diet, sleep, cognitive engagement), and a false sense of security for non-carriers. Additionally, direct-to-consumer (DTC) tests typically only genotype the common ε2, ε3, ε4 variants and may miss rare or population-specific alleles. The evidence is primarily observational (human-moderate). Conclusion: exercise is beneficial for everyone, but personalized training based solely on APOE genotype is not yet evidence-based.